Last quarter (Q4 2022), 10x Genomics's total revenue was $156.23M, an increase of 8.85% from the same quarter last year. In Q4, 10x Genomics's net income was $-17.21M. See 10x Genomics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 516.41M	$ 516.41M	$ 490.49M	$ 298.85M	$ 245.89M	$ 146.31M
Cost of Revenue	$ 120.39M	$ 120.39M	$ 74.09M	$ 58.47M	$ 61.03M	$ 28.66M
Gross Profit	$ 396.02M	$ 396.02M	$ 416.40M	$ 240.38M	$ 184.86M	$ 117.65M
Operating Expense	$ 563.97M	$ 563.97M	$ 469.31M	$ 325.70M	$ 213.93M	$ 166.05M
Operating Income	$ -167.94M	$ -167.94M	$ -52.91M	$ -85.32M	$ -29.07M	$ -48.40M
Net Non Operating Interest Income Expense	$ 6.17M	$ 6.17M	$ -660.00K	$ -150.00K	$ -274.00K	$ -1.39M
Other Income Expense	$ -198.00K	$ -198.00K	$ -142.00K	$ -449.00M	$ -1.69M	$ -62.61M
Pretax Income	$ -161.97M	$ -161.97M	$ -53.72M	$ -534.48M	$ -31.03M	$ -112.40M
Tax Provision	$ 4.03M	$ 4.03M	$ 4.51M	$ 8.26M	$ 218.00K	$ 87.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -166.00M	$ -166.00M	$ -58.22M	$ -542.73M	$ -31.25M	$ -112.48M
Basic EPS	$ -1.47	$ -1.46	$ -0.53	$ -5.37	$ -0.80	$ -1.36
Diluted EPS	$ -1.47	$ -1.46	$ -0.53	$ -5.37	$ -0.80	$ -1.36
Basic Average Shares	$ 455.42M	$ 113.86M	$ 110.35M	$ 101.15M	$ 39.09M	$ 82.89M
Diluted Average Shares	$ 455.42M	$ 113.86M	$ 110.35M	$ 101.15M	$ 39.09M	$ 82.89M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 684.35M	$ 684.35M	$ 543.40M	$ 384.17M	$ 274.96M	$ 194.71M
Net Income From Continuing And Discontinued Operation	$ -166.00M	$ -166.00M	$ -58.22M	$ -542.73M	$ -31.25M	$ -112.48M
Normalized Income	$ -166.00M	$ -166.00M	$ -58.70M	$ -213.98M	$ -30.15M	$ -66.96M
Interest Expense	$ 476.00K	$ 476.00K	$ 866.00K	$ 1.68M	$ 3.08M	$ 2.41M
EBIT	$ -161.50M	$ -161.50M	$ -52.85M	$ -532.79M	$ -27.95M	$ -109.99M
EBITDA	$ -128.49M	$ -128.49M	$ -24.59M	$ -513.77M	$ -20.89M	$ -106.08M

Currency in USD

10x Genomics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing